TITLE

Oral Contraceptive Hormones and Blood Coagulability

AUTHOR(S)
Thomson, Jean M.; Poller, L.
PUB. DATE
July 1965
SOURCE
British Medical Journal;7/31/1965, Vol. 2 Issue 5456, p270
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64059596

 

Related Articles

  • Women who developed thromboembolic events while taking oral contraceptives or HT had high prevalence of thrombophilia. Cona, Christen; Harris, Jason; Southall, Jennifer // Hem/Onc Today;9/25/2010, Vol. 11 Issue 18, p27 

    The article deals with a study which affirms the high prevalence of thrombophilia in women receiving oral contraceptives or hormone therapy, published in an issue of "Blood Coagulation & Fibrinolysis."

  • Research looks at safety of oral contraceptives.  // World Health;Jul/Aug97, Vol. 50 Issue 4, p37 

    Focuses on the safety of using oral contraceptive. Hormones which are contained in the pills; Oral contraceptives and stroke; Oral contraceptives and heart attack.

  • ACOG Issues Report on Hormonal Contraception.  // American Family Physician;2/1/1995, Vol. 51 Issue 2, p543 

    Focuses on hormonal contraceptive methods. Noncontraceptive benefits of oral contraceptives; Injectable contraceptives; Contraceptive implants.

  • Is there a standard thrombophilia screen?  // Pulse;10/21/2002, Vol. 62 Issue 40, p88 

    Discusses a standard thrombophilia screening process for a woman with a family history of deep vein thrombosis who wants a combined oral contraceptive. Full blood count and platelet count; Coagulation screen; Measurement of proteins.

  • Hormone replacement therapy and risk of thromboembolism. Lowe, Gordon // Journal of the British Menopause Society;2003 Supplement, Vol. 9, p15 

    The article informs that the risk of venous thromboembolism is increased to three fold by combined oral contraceptives, oral hormone replacement therapy and the selective receptor modulators. Activated protein C resistance, low levels of coagulation inhibitors and tissue factor pathway inhibitor...

  • Summaries for Patients. Screening for Coronary Heart Disease With Electrocardiography: U.S. Preventive Services Task Force Recommendation Statement.  // Annals of Internal Medicine;10/2/2012, Vol. 157 Issue 7, pI-38 

    No abstract available.

  • Elective surgery and the pill.  // British Medical Journal;9/4/1976, Vol. 2 Issue 6035, p546 

    Focuses on the problems brought in by the prescription of estrogens as oral contraceptives and as hormone replacement treatment for menopausal symptoms. Changes in the blood vessel wall; Evidence of the increased risk of chromboembolic disease; Risk of unwanted pregnancy.

  • New choices in hormone-based contraception. Martin, Kathryn // Drug Topics;5/5/2003 Supplement, Vol. 147 Issue 9, p12S 

    Focuses on a range of options in hormonal contraception. Two major advances in hormone-based contraception; Factors affecting the use of oral contraceptives; Safety considerations; Effect of weight on efficacy; Extended cycle regimens; Other contraceptive options.

  • New Contraceptive Choices.  // Population Reports;Apr2005, Vol. 32 Issue 3, p1 

    Focuses on selected innovations in contraceptives. Vaginal rings; Transdermal patches; Combined injectables; Condoms; Oral contraceptives; Transcervical sterilization; Male hormonal contraceptives.

  • Pill risk was known.  // Mail on Sunday;2/ 9/2014, p111 

    Following your story last week, I would like to clarify the advice that the Medicines and Healthcare Products Regulatory Agency (MHRA) has given about combined oral contraceptives. The risk of blood clots with combined hormonal contraceptives is small and was already known. It is incorrect to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics